Literature DB >> 2404591

Detection of c-K-ras mutations in fine needle aspirates from human pancreatic adenocarcinomas.

D Shibata1, C Almoguera, K Forrester, J Dunitz, S E Martin, M M Cosgrove, M Perucho, N Arnheim.   

Abstract

Formalin-fixed paraffin-embedded tissue specimens obtained by fine needle aspiration of pancreatic masses from 47 patients were examined retrospectively for cytology and the presence of mutant c-K-ras oncogenes. Point mutations of c-K-ras in codon 12 were detected by RNA-DNA RNAse A mismatch cleavage after in vitro DNA amplification of the cellular c-K-ras sequences by the polymerase chain reaction. Of the 36 patients with pancreatic adenocarcinoma, mutant c-K-ras oncogenes were detected in 18 of 25 (72%) with malignant cytologies, 2 of 8 (25%) with atypical cytologies, and 0 of 3 with benign aspiration cytologies. The remaining 11 patients without pancreatic adenocarcinomas did not have mutant c-K-ras genes detectable by the assay. The diagnosis of pancreatic adenocarcinoma was based upon clinical follow-up. The presence of mutant c-K-ras oncogenes did not significantly affect survival in the patients studied. Mutant c-K-ras genes were found at the time of initial clinical presentation in the majority of pancreatic adenocarcinomas, suggesting an important role of the mutation in oncogenesis. In conjunction with cytology, our approach represents an application for cancer diagnosis at the molecular genetic level.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2404591

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

1.  Detection of k-ras gene point mutation in fine needle aspiration and pancreatic juice by sequence special primer method and its clinical significance.

Authors:  Xun-Liang Liu; Cun-Cai Dai; Yi Miao; Jing-Hui Du; Zhao-Song Zhang; Shu-Zhen Chen
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

Review 2.  Emerging role of the KRAS-PDK1 axis in pancreatic cancer.

Authors:  Riccardo Ferro; Marco Falasca
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 3.  K-ras mutation and pancreatic adenocarcinoma.

Authors:  C Caldas; S E Kern
Journal:  Int J Pancreatol       Date:  1995-08

Review 4.  The use of molecular technology in the differentiation of pancreatic cancer and chronic pancreatitis.

Authors:  S R Bramhall
Journal:  Int J Pancreatol       Date:  1998-04

5.  Molecular diagnosis of exocrine pancreatic cancer using a percutaneous technique.

Authors:  D B Evans; M L Frazier; C Charnsangavej; R L Katz; L Larry; J L Abbruzzese
Journal:  Ann Surg Oncol       Date:  1996-05       Impact factor: 5.344

6.  Clinical significance of K-ras and c-erbB-2 mutations in pancreatic adenocarcinoma and chronic pancreatitis.

Authors:  Renata Talar-Wojnarowska; Anita Gasiorowska; Beata Smolarz; Hanna Romanowicz-Makowska; Janusz Strzelczyk; Adam Janiak; Andrzej Kulig; Ewa Malecka-Panas
Journal:  Int J Gastrointest Cancer       Date:  2005

7.  Overexpression of c-Ki-ras and c-fos in human pancreatic carcinomas.

Authors:  K Wakita; H Ohyanagi; K Yamamoto; T Tokuhisa; Y Saitoh
Journal:  Int J Pancreatol       Date:  1992-02

8.  Detection of pancreatic carcinoma: diagnostic value of K-ras mutations in circulating DNA from serum.

Authors:  L Theodor; E Melzer; M Sologov; G Idelman; E Friedman; S Bar-Meir
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

9.  Expression of glutathione S-transferases in normal and malignant pancreas: an immunohistochemical study.

Authors:  J D Collier; M K Bennett; A Hall; A R Cattan; R Lendrum; M F Bassendine
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

10.  Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation.

Authors:  A Hoorens; N R Lemoine; E McLellan; T Morohoshi; T Kamisawa; P U Heitz; B Stamm; J Rüschoff; B Wiedenmann; G Klöppel
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.